My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 112

    1.

    Clotting state after cardioversion of atrial fibrillation: a haemostasis index could detect the relationship with the arrhythmia duration.

    Hatzinikolaou-Kotsakou E, Kartasis Z, Tziakas D, Stakos D, Hotidis A, Chalikias G, Bourikas G, Hatseras DI.

    Thromb J. 2005 Mar 6;3(1):2.PMID: 15748296 [PubMed - as supplied by publisher]Related articlesFree article

    2.

    Plasma fibrinogen and fibrin D-dimer in patients with atrial fibrillation: effects of cardioversion to sinus rhythm.

    Lip GY, Rumley A, Dunn FG, Lowe GD.

    Int J Cardiol. 1995 Oct;51(3):245-51.PMID: 8586473 [PubMed - indexed for MEDLINE]Related articles

    3.

    The potential of D-dimer levels as a useful clinical marker of clotting state after the return of sinus rhythm.

    Hatzinikolaou-Kotsakou E, Hatseras DI.

    Future Cardiol. 2006 Jan;2(1):55-61.PMID: 19804132 [PubMed - in process]Related articles

    4.

    Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation.

    Marín F, Roldán V, Climent VE, Ibáñez A, García A, Marco P, Sogorb F, Lip GY.

    Heart. 2004 Oct;90(10):1162-6.PMID: 15367514 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Activation of coagulation occurs after electrical cardioversion in patients with chronic atrial fibrillation despite optimal anticoagulation with warfarin.

    Jacob K, Talwar S, Copplestone A, Gilbert TJ, Haywood GA.

    Int J Cardiol. 2004 May;95(1):83-8.PMID: 15159043 [PubMed - indexed for MEDLINE]Related articles

    6.

    Plasma levels of NT-pro-BNP in patients with atrial fibrillation before and after electrical cardioversion.

    Shin DI, Jaekel K, Schley P, Sause A, Müller M, Fueth R, Scheffold T, Guelker H, Horlitz M.

    Z Kardiol. 2005 Dec;94(12):795-800.PMID: 16382379 [PubMed - indexed for MEDLINE]Related articles

    7.

    Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: evidence for intermediate elevated levels of intravascular thrombogenesis.

    Lip GY, Lowe GD, Rumley A, Dunn FG.

    Am Heart J. 1996 Apr;131(4):724-30.PMID: 8721646 [PubMed - indexed for MEDLINE]Related articles

    8.

    Coagulation indicators in patients with paroxysmal atrial fibrillation: effects of electric and pharmacologic cardioversion.

    Giansante C, Fiotti N, Miccio M, Altamura N, Salvi R, Guarnieri G.

    Am Heart J. 2000 Sep;140(3):423-9.PMID: 10966540 [PubMed - indexed for MEDLINE]Related articles

    9.

    [Impact of electrical shock waveform and paddle positions on efficacy of direct current cardioversion for atrial fibrillation]

    Stanaitiene G, Babarskiene RM.

    Medicina (Kaunas). 2008;44(9):665-72. Lithuanian. PMID: 18971603 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    [Late recurrences of atrial fibrillation in patients after direct-current cardioversion]

    Gurciková M, Kaluzay J, Remisová S, Jurkovicová O, Pontuch P.

    Vnitr Lek. 2008 Jun;54(6):604-8. Slovak. PMID: 18672570 [PubMed - indexed for MEDLINE]Related articles

    11.

    Study of atrial function using echocardiographic automatic boundary detection following external or internal cardioversion for idiopathic atrial fibrillation.

    Kranidis A, Kappos K, Lekatsas I, Karabinos I, Koulouris S, Andrikopoulos G, Bouki T, Kotsakis A, Exadaktylos N.

    Hellenic J Cardiol. 2006 Mar-Apr;47(2):72-7.PMID: 16752526 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Evolution of plasma D-dimer and fibrinogen in witnessed onset of paroxysmal atrial fibrillation.

    Wang TL, Hung CR, Chang H.

    Cardiology. 2004;102(2):115-8. Epub 2004 May 7.PMID: 15133314 [PubMed - indexed for MEDLINE]Related articles

    13.
    14.

    C-reactive protein but not atrial dysfunction predicts recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function.

    Lombardi F, Tundo F, Belletti S, Mantero A, Melzi D'eril GV.

    J Cardiovasc Med (Hagerstown). 2008 Jun;9(6):581-8.PMID: 18475126 [PubMed - indexed for MEDLINE]Related articles

    15.

    Stunning of the left atrium after pharmacological cardioversion of atrial fibrillation.

    Zapolski T, Wysokiński A.

    Kardiol Pol. 2005 Sep;63(3):254-62; discussion 263-4.PMID: 16180181 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Increased intracardiovascular clotting in patients with chronic atrial fibrillation.

    Kumagai K, Fukunami M, Ohmori M, Kitabatake A, Kamada T, Hoki N.

    J Am Coll Cardiol. 1990 Aug;16(2):377-80.PMID: 2373815 [PubMed - indexed for MEDLINE]Related articles

    17.
    18.

    Candesartan, NT-proBNP and recurrence of atrial fibrillation after electrical cardioversion.

    Tveit A, Seljeflot I, Grundvold I, Abdelnoor M, Arnesen H, Smith P.

    Int J Cardiol. 2009 Jan 9;131(2):234-9. Epub 2008 Jan 16.PMID: 18201783 [PubMed - indexed for MEDLINE]Related articles

    19.

    The dubious value of echocardiographic and plasma ANP measurements in predicting outcome of cardioversion in patients with persistent atrial fibrillation.

    Wozakowska-Kapłon B, Opolski G.

    Int J Cardiol. 2005 Sep 1;103(3):280-5.PMID: 16098390 [PubMed - indexed for MEDLINE]Related articles

    20.

    Signal-averaged P wave reflects change in atrial electrophysiological substrate afforded by verapamil following cardioversion from atrial fibrillation.

    Redfearn DP, Skanes AC, Lane J, Stafford PJ.

    Pacing Clin Electrophysiol. 2006 Oct;29(10):1089-95.PMID: 17038141 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk